Detection of BRAF, NRAS, KIT, GNAQ, GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis

Target inhibitors are used for melanoma treatment, and their effectiveness depends on the tumor genotype. We developed a diagnostic biochip for the detection of 39 clinically relevant somatic mutations in the BRAF, NRAS, KIT, GNAQ, GNA11, MAP2K1 and MAP2K2 genes. We used multiplex locked nucleic aci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Emelyanova, Marina, Ghukasyan, Lilit, Abramov, Ivan, Ryabaya, Oxana, Stepanova, Evgenia, Kudryavtseva, Anna, Sadritdinova, Asiya, Dzhumakova, Cholpon, Belysheva, Tatiana, Surzhikov, Sergey, Lyubchenko, Lyudmila, Zasedatelev, Alexander, Nasedkina, Tatiana
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581030/
https://ncbi.nlm.nih.gov/pubmed/28881731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados